Adenomyosis and Fertility: What We Know, What We Don’t, and IVF Considerations
A nuanced guide to adenomyosis, symptoms, ultrasound/MRI diagnosis, and the imperfect evidence around fertility treatment.
The decision in one minute
The useful question is narrower than it first appears: Adenomyosis can coexist with endometriosis and fibroids and may be associated with lower implantation or pregnancy rates in some studies. The evidence is heterogeneous, so treatment is individualized rather than one-size-fits-all.
A nuanced guide to adenomyosis, symptoms, ultrasound/MRI diagnosis, and the imperfect evidence around fertility treatment. This page stays focused on uterine factor, so you can use the information to make one concrete next decision instead of collecting more disconnected facts.
What this changes in practice
In practice, Adenomyosis occurs when endometrial-type tissue is present within the uterine muscle.
In practice, Symptoms can include heavy bleeding, painful periods, and an enlarged or tender uterus, but some people are asymptomatic.
| Check | Why it belongs in your decision |
|---|---|
| Point 1 | Adenomyosis occurs when endometrial-type tissue is present within the uterine muscle. |
| Point 2 | Symptoms can include heavy bleeding, painful periods, and an enlarged or tender uterus, but some people are asymptomatic. |
| Point 3 | Ultrasound and MRI can support diagnosis; there is no single perfect noninvasive test. |
| Point 4 | Studies suggest associations with implantation and pregnancy outcomes, especially in IVF, but patient populations and diagnostic definitions vary. |
| Point 5 | Treatment must account for age, symptoms, embryo plans, and how quickly pregnancy is desired. |
Where people get tripped up
A detail people often miss: Ultrasound and MRI can support diagnosis; there is no single perfect noninvasive test.
In practice, Studies suggest associations with implantation and pregnancy outcomes, especially in IVF, but patient populations and diagnostic definitions vary.
How to turn the information into a better decision
A detail people often miss: Treatment must account for age, symptoms, embryo plans, and how quickly pregnancy is desired.
The number or result needs context. The safest interpretation is the one that answers the question the test, tracker, symptom, or product was actually designed to answer—and stops there.
Put this inside the larger fertility picture
Age, cycle pattern, time trying, prior pregnancy history, uterine/tubal factors, and semen factors can all change how the same consumer result or lab value is interpreted.
ACOG recommends reviewing medications, supplements, chronic conditions, immunizations, nutrition, genetic history, and STI screening as appropriate before pregnancy. That broad preconception work is often more valuable than optimizing one isolated metric.
ASRM recommends evaluation after 12 months of trying for women under 35, after 6 months at 35 or older, and more promptly over 40 or when a known fertility-related condition is present.
What to bring to a clinician or product decision
Bring the actual data, not just the conclusion an app gave you: cycle dates, screenshots or logs if relevant, laboratory units and reference ranges, medication and supplement labels, and the dates of prior tests.
Ask what the result predicts well, what it does not predict, and what decision changes because of it. If nobody can name the decision, more testing may not be buying you much.
When a product is involved, compare total daily cost, adherence burden, ingredient or measurement transparency, and whether the feature solves a problem you actually have.
Save-this checklist
- Adenomyosis occurs when endometrial-type tissue is present within the uterine muscle.
- Symptoms can include heavy bleeding, painful periods, and an enlarged or tender uterus, but some people are asymptomatic.
- Ultrasound and MRI can support diagnosis; there is no single perfect noninvasive test.
- Studies suggest associations with implantation and pregnancy outcomes, especially in IVF, but patient populations and diagnostic definitions vary.
- Treatment must account for age, symptoms, embryo plans, and how quickly pregnancy is desired.
Decision-note builder
Use this to turn the topic into a short note you can save before a clinician visit or shopping decision.
Frequently asked questions
Can adenomyosis and fertility: what we know, what we don’t, and ivf considerations tell me whether I will get pregnant?
No single test, tracker, supplement, or diagnosis can answer that on its own. Fertility depends on multiple factors, and the same finding can have different implications depending on age and the rest of the evaluation.
When should I ask for a fertility evaluation?
ASRM recommends evaluation after 12 months of trying for women under 35, after 6 months at 35 or older, and more promptly over 40 or when a known fertility-related condition is present.
Should my partner be evaluated too?
When applicable, yes. ASRM recommends parallel evaluation of the male partner, including semen evaluation, rather than assuming the issue is only on one side.
Should I change medication or supplements based on this page?
No. Use the page to prepare questions. ACOG recommends reviewing prescription drugs, over-the-counter products, supplements, and herbal products during preconception care.
Related reading
Primary guidance used
Guidance and product authorizations change. When timing or treatment matters, use the current linked guidance or a clinician rather than relying on a cached summary.